MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

Catalog Number 1125300-18

Device Problems Deflation Problem (1149); Inflation Problem (1310); Difficult to Remove (1528); Improper or Incorrect Procedure or Method (2017); Physical Resistance (2578)

Patient Problems Intimal Dissection (1333); Angina (1710); Bradycardia (1751); Low Blood Pressure/ Hypotension (1914)

Event Date 07/07/2017

Event Type  Injury  

Manufacturer Narrative

(b)(4).Internal file number - (b)(4): during processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The device was not returned for analysis.Per the xience alpine everolimus eluting coronary stent system instructions for use the device should be prepared by removing air from the system prior to insertion in the anatomy.Device preparation prior to use instructs the user to orientate the delivery system vertically and remove air from the system.The investigation determined the reported difficulties appear to be related to circumstances of the procedure and subsequent use error as it is likely that as the sds was advanced resistance was met with the 75% stenosed anatomy resulting in the reported physical resistance.Preparation of the device inside the anatomy resulted in the reported inflation issue as the balloon was inflated with air.Furthermore, the air in the system combined with the mildly tortuous anatomy resulted in the inflation lumen being constricted leading to the reported deflation issue and subsequent difficulty removing as the balloon was removed partially inflated.The reported device issues likely contributed to the reported patient effects; however, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of dissection, angina and hypotension are listed in the xience alpine, everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.There is no indication of a product quality issue with respect to manufacture, design or labeling.

Event Description

It was reported the procedure was to treat a 75% stenosis in the proximal and mid circumflex (cx) artery.The lesions were pre-dilated with trek balloons.A xience alpine stent was successfully deployed in the mid cx.The 3.0x18mm xience alpine stent delivery system (sds) was advanced to the proximal lesion after multiple attempts.The sds was prepped inside the anatomy.The balloon was inflated to 10 atmospheres; however, under fluoroscopy the balloon was full of air.The balloon was unable to be deflated.Double negative was applied with the indeflator, but the balloon would not deflate.A syringe was used, negative pressure was pulled for 20 to 30 seconds, which partially deflated the balloon.The patient became hypotensive, heart rate dropped, and the patient experienced chest pain.Resistance was met with the deployed stent and the anatomy during retraction as the balloon was removed partially inflated and subsequently the left main dissected.The patient was taken for emergency coronary artery bypass graft surgery.The patient is stable and recovering.No additional information was provided.

Manufacturer Narrative

(b)(4).The investigation determined the reported physical resistance appears to be related to circumstances of the procedure as it is likely that as the stent delivery system (sds) was advanced, resistance was met with the 75% stenosed anatomy.It is possible that during preparation an inadequate connection between the syringe/indeflator and sds resulted in the reported inflation issue as the balloon was inflated with air; however, this cannot be confirmed.The air in the system combined with the mildly tortuous anatomy likely resulted in the inflation lumen being constricted leading to the reported deflation issue and subsequent difficulty removing as the balloon was removed partially inflated.There is no indication of a product quality issue with respect to manufacture, design or labeling.

Event Description

Follow up information received stating that the device was not prepped inside the patient anatomy as initially reported.The device was prepped outside the anatomy per the instructions for use.

• Brand Name: XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
• Type of Device: DRUG ELUTING CORONARY STENT SYSTEM
• Manufacturer (Section D): AV-TEMECULA-CT; abbott vascular; 26531 ynez road; temecula CA 92591 4628
• Manufacturer (Section G): ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168; abbott vascular; 26531 ynez road; temecula CA 92591 4628
• Manufacturer Contact: connie speck ; abbott vascular; 26531 ynez road; temecula, CA 92591-4628 ; 9519143996
• MDR Report Key: 6757282
• MDR Text Key: 81505803
• Report Number: 2024168-2017-06295
• Device Sequence Number: 1
• Product Code: NIQ
• UDI-Device Identifier: 08717648199356
• UDI-Public: 08717648199356
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: P110019
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: company representative,health
• Reporter Occupation: Health Professional
• Remedial Action: Other
• Type of Report: Initial,Followup
• Report Date: 08/04/2017

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 03/29/2019
• Device Catalogue Number: 1125300-18
• Device Lot Number: 6031461
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Initial Date Manufacturer Received: 07/07/2017
• Initial Date FDA Received: 08/01/2017
• Supplement Dates Manufacturer Received: 08/01/2017
• Supplement Dates FDA Received: 08/04/2017
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Date Device Manufactured: 03/01/2016
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Hospitalization; Required Intervention; Disability